Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Approval for Bromfenac Ophthalmic Solution 0.09%. The Company enclosed herewith its press release.
The above information is a part of company’s filings submitted to BSE.